Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-060751
Filing Date
2020-11-30
Accepted
2020-11-30 17:11:08
Documents
1
Period of Report
2020-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3341
  Complete submission text file 0001209191-20-060751.txt   4746
Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98011
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 201358897

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations